» Articles » PMID: 37251180

Gold-Nanoparticles-Enhanced Production of Reactive Oxygen Species in Cells at Spread-Out Bragg Peak Under Proton Beam Radiation

Overview
Journal ACS Omega
Specialty Chemistry
Date 2023 May 30
PMID 37251180
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigates the radiobiological effects of gold nanoparticles (GNPs) as radiosensitizers for proton beam therapy (PBT). Specifically, we explore the enhanced production of reactive oxygen species (ROS) in GNP-loaded tumor cells irradiated by a 230 MeV proton beam in a spread-out Bragg peak (SOBP) zone obtained by a passive scattering system. Our findings indicate that the radiosensitization enhancement factor is 1.24 at 30% cell survival fraction, 8 days after 6 Gy proton beam irradiation. Since protons deposit the majority of their energy at the SOBP region and interact with GNPs to induce more ejected electrons from the high-Z GNPs, these ejected electrons then react with water molecules to produce excessive ROS that can damage cellular organelles. Laser scanning confocal microscopy reveals the excessive ROS induced inside the GNP-loaded cells immediately after proton irradiation. Furthermore, the damage to cytoskeletons and mitochondrial dysfunction in GNP-loaded cells caused by the induced ROS becomes significantly severe, 48 h after proton irradiation. Our biological evidence suggests that the cytotoxicity of GNP-enhanced ROS production has the potential to increase the tumoricidal efficacy of PBT.

Citing Articles

An Evaluation of the Potential Radiosensitization Effect of Spherical Gold Nanoparticles to Induce Cellular Damage Using Different Radiation Qualities.

Engelbrecht-Roberts M, Miles X, Vandevoorde C, de Kock M Molecules. 2025; 30(5).

PMID: 40076263 PMC: 11902069. DOI: 10.3390/molecules30051038.


Exploring the Potential of Gold Nanoparticles in Proton Therapy: Mechanisms, Advances, and Clinical Horizons.

Carbone G, Mariano S, Gabriele A, Cennamo S, Primiceri V, Aziz M Pharmaceutics. 2025; 17(2).

PMID: 40006543 PMC: 11859620. DOI: 10.3390/pharmaceutics17020176.


Gold Nanoparticle-Enhanced Production of Reactive Oxygen Species for Radiotherapy and Phototherapy.

Nguyen V, Tsai S, Cho I, Chao T, Hsiao I, Huang H Nanomaterials (Basel). 2025; 15(4).

PMID: 39997879 PMC: 11858237. DOI: 10.3390/nano15040317.


Enhancing Proton Therapy Efficacy Through Nanoparticle-Mediated Radiosensitization.

Ma J, Shen H, Mi Z Cells. 2024; 13(22).

PMID: 39594590 PMC: 11593106. DOI: 10.3390/cells13221841.


Microdosimetric Simulation of Gold-Nanoparticle-Enhanced Radiotherapy.

Azarkin M, Kirakosyan M, Ryabov V Int J Mol Sci. 2024; 25(17).

PMID: 39273472 PMC: 11395083. DOI: 10.3390/ijms25179525.


References
1.
Enferadi M, Fu S, Hong J, Tung C, Chao T, Wey S . Radiosensitization of ultrasmall GNP-PEG-cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons. Int J Radiat Biol. 2017; 94(2):124-136. DOI: 10.1080/09553002.2018.1407462. View

2.
Mitteer R, Wang Y, Shah J, Gordon S, Fager M, Butter P . Proton beam radiation induces DNA damage and cell apoptosis in glioma stem cells through reactive oxygen species. Sci Rep. 2015; 5:13961. PMC: 4564801. DOI: 10.1038/srep13961. View

3.
Suckert T, Muller J, Beyreuther E, Azadegan B, Bruggemann A, Butof R . High-precision image-guided proton irradiation of mouse brain sub-volumes. Radiother Oncol. 2020; 146:205-212. DOI: 10.1016/j.radonc.2020.02.023. View

4.
Marshall T, Chaudhary P, Michaelidesova A, Vachelova J, Davidkova M, Vondracek V . Investigating the Implications of a Variable RBE on Proton Dose Fractionation Across a Clinical Pencil Beam Scanned Spread-Out Bragg Peak. Int J Radiat Oncol Biol Phys. 2016; 95(1):70-77. PMC: 4838672. DOI: 10.1016/j.ijrobp.2016.02.029. View

5.
Wolfe T, Guidelli E, Gomez J, Baffa O, Nicolucci P . Experimental assessment of gold nanoparticle-mediated dose enhancement in radiation therapy beams using electron spin resonance dosimetry. Phys Med Biol. 2015; 60(11):4465-80. DOI: 10.1088/0031-9155/60/11/4465. View